Medifast, Inc. (MED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1157424,
    "name": "Medifast, Inc.",
    "stock_name": "Medifast, Inc.",
    "full_name": "Medifast, Inc.",
    "name_url": "stocks-analysis/medifast-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "10.86",
    "chg": -0.15,
    "chgp": "-1.36%",
    "dir": -1,
    "prev_price": "11.01",
    "mcapval": "151.90",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US58470H1014",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "625.92 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medifast-inc-1157424-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medifast, Inc. Hits 52-Week Low at $11.25 Amid Ongoing Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medifast-inc-hits-52-week-low-at-1125-amid-ongoing-struggles-3673988",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MedifastInc_priceRelatedfactors_3673988.png",
        "date": "2025-11-05 16:30:32",
        "description": "Medifast, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. The company reported a sharp drop in net profit and operating cash flow, alongside the lowest net sales in recent history. Despite maintaining a high return on equity, it has faced negative results for 12 consecutive quarters."
      },
      {
        "title": "Medifast, Inc. Experiences Revision in Its Stock Evaluation Amidst Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medifast-inc-changes-valuation-grade-from-expensive-to-attractive-amid-market-volatility-3667070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MedifastInc_valuationdot_3667070.png",
        "date": "2025-11-03 15:48:23",
        "description": "Medifast, Inc. has experienced a valuation adjustment amid challenging financial metrics, including a negative return on equity and significant operational hurdles. Compared to peers, its valuation ratios highlight broader industry difficulties. Year-to-date returns are down substantially, reflecting competitive pressures and operational challenges in the current market environment."
      },
      {
        "title": "Medifast, Inc. Experiences Valuation Adjustment Amidst Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medifasts-valuation-grade-changes-from-expensive-to-attractive-amid-market-volatility-3640793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MedifastInc_valuationdot_3640793.png",
        "date": "2025-10-20 16:30:37",
        "description": "Medifast, Inc. has recently adjusted its valuation amid ongoing financial challenges, with a notable decline in its annual return. Key metrics indicate a low price-to-book value and negative performance indicators. Compared to peers, Medifast's valuation appears more favorable, suggesting a complex industry positioning for investors to consider."
      },
      {
        "title": "Is Medifast, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-medifast-inc-technically-bullish-or-bearish-3545446",
        "imagepath": "",
        "date": "2025-09-20 19:11:57",
        "description": "As of 2 September 2025, the technical trend for Medifast, Inc. has changed from sideways to mildly bearish. The weekly MACD and KST indicators are mildly bullish, while the monthly MACD is also mildly bullish, suggesting some positive momentum. However, the daily moving averages indicate a mildly bearish stance, and the Bollinger Bands show a mixed signal with a bullish weekly and mildly bearish monthly outlook. The Dow Theory reflects a mildly bullish weekly trend but no trend on the monthly basis. \n\nIn terms of performance, Medifast has underperformed the S&P 500 significantly over the longer term, with a year-to-date return of -17.31% compared to the S&P 500's 12.22%, and a 1-year return of -22.58% against the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven by the daily moving averages and mixed signals from other indicators...."
      },
      {
        "title": "Is Medifast, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-medifast-inc-overvalued-or-undervalued-3542154",
        "imagepath": "",
        "date": "2025-09-20 17:46:05",
        "description": "As of 7 August 2025, the valuation grade for Medifast, Inc. has moved from expensive to attractive, indicating a shift in perception regarding its valuation. The company appears to be undervalued, particularly given its Price to Book Value of 0.66 and an EV to EBIT ratio of 2.98, despite the challenges reflected in its negative earnings metrics. \n\nIn comparison to its peers, Medifast's P/E ratio stands at 62.80, while Thoughtworks Holding, Inc. and Chegg, Inc. exhibit significantly lower P/E ratios of -25.45 and -22.62, respectively, highlighting the relative attractiveness of Medifast within this group. Additionally, the company has underperformed against the S&P 500, with a year-to-date return of -17.31% compared to the index's 12.22%, and a staggering -91.61% return over the past five years, suggesting that while the stock may be undervalued, it has faced significant headwinds in the market...."
      }
    ],
    "total": 10,
    "sid": "1157424",
    "stock_news_url": "https://www.marketsmojo.com/news/medifast-inc-1157424"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Medifast, Inc. Hits 52-Week Low at $11.25 Amid Ongoing Struggles

2025-11-05 16:30:32

Medifast, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. The company reported a sharp drop in net profit and operating cash flow, alongside the lowest net sales in recent history. Despite maintaining a high return on equity, it has faced negative results for 12 consecutive quarters.

Medifast, Inc. Experiences Revision in Its Stock Evaluation Amidst Financial Challenges

2025-11-03 15:48:23

Medifast, Inc. has experienced a valuation adjustment amid challenging financial metrics, including a negative return on equity and significant operational hurdles. Compared to peers, its valuation ratios highlight broader industry difficulties. Year-to-date returns are down substantially, reflecting competitive pressures and operational challenges in the current market environment.

Medifast, Inc. Experiences Valuation Adjustment Amidst Challenging Market Conditions

2025-10-20 16:30:37

Medifast, Inc. has recently adjusted its valuation amid ongoing financial challenges, with a notable decline in its annual return. Key metrics indicate a low price-to-book value and negative performance indicators. Compared to peers, Medifast's valuation appears more favorable, suggesting a complex industry positioning for investors to consider.

Is Medifast, Inc. technically bullish or bearish?

2025-09-20 19:11:57

As of 2 September 2025, the technical trend for Medifast, Inc. has changed from sideways to mildly bearish. The weekly MACD and KST indicators are mildly bullish, while the monthly MACD is also mildly bullish, suggesting some positive momentum. However, the daily moving averages indicate a mildly bearish stance, and the Bollinger Bands show a mixed signal with a bullish weekly and mildly bearish monthly outlook. The Dow Theory reflects a mildly bullish weekly trend but no trend on the monthly basis. In terms of performance, Medifast has underperformed the S&P 500 significantly over the longer term, with a year-to-date return of -17.31% compared to the S&P 500's 12.22%, and a 1-year return of -22.58% against the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven by the daily moving averages and mixed signals from other indicators....

Is Medifast, Inc. overvalued or undervalued?

2025-09-20 17:46:05

As of 7 August 2025, the valuation grade for Medifast, Inc. has moved from expensive to attractive, indicating a shift in perception regarding its valuation. The company appears to be undervalued, particularly given its Price to Book Value of 0.66 and an EV to EBIT ratio of 2.98, despite the challenges reflected in its negative earnings metrics. In comparison to its peers, Medifast's P/E ratio stands at 62.80, while Thoughtworks Holding, Inc. and Chegg, Inc. exhibit significantly lower P/E ratios of -25.45 and -22.62, respectively, highlighting the relative attractiveness of Medifast within this group. Additionally, the company has underperformed against the S&P 500, with a year-to-date return of -17.31% compared to the index's 12.22%, and a staggering -91.61% return over the past five years, suggesting that while the stock may be undervalued, it has faced significant headwinds in the market....

View All News